New vaccine targets Hepatitis B eradication (2:08)
Aug. 5 - Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to stop the disease in its tracks and is currently seeking approval for its use in the United States and Europe. Elly Park reports. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.